Factors a Government Should Consider When Intervening in the Market for R&D
Question
Firms are protected by Intellectual Property (IP) laws when they successfully develop new technology or product from Research & Development (R&D). However they often do not invest sufficient resources and hence governments need to play a critical role to encourage more R&D.
(b) Discuss the factors that governments should consider when deciding to intervene in the market for R&D. [15]
Answer
When a government allocates resources to R&D it is intervening in the market, and the case for doing so rests on a perceived market failure: R&D behaves as a merit good — socially desirable, yet under-provided and under-consumed when left to the free market. I argue that the government’s central consideration is the standard cost–benefit weighing of intervention — the size of the external benefit it can internalise against the opportunity cost and risk of government failure — and that this verdict, not any single rationale, determines whether and how far it should act.
Positive externalities. The first factor calling for intervention is the positive externality generated by R&D. A private producer weighs only its marginal private cost and benefit, ignoring the external benefit to third parties — for instance, the way one innovation seeds further creative work that society values. With no negative externality (, so ), the free market produces at where , below the social optimum where , leaving R&D under-consumed by and a deadweight welfare loss from the forgone net social benefit. The corrective is a per-unit subsidy equal to the marginal external benefit at , lowering to so the new private equilibrium coincides with . The government must therefore consider the size of the external benefit and of , since the subsidy bill is roughly — and this varies by country and by the state of its R&D.
Non-excludability and IP. A second factor is the non-excludable character of knowledge: a competitive market gives too little incentive to invest because rivals can free-ride on a new technology. The government’s instrument here is regulation rather than a subsidy — intellectual property rights. Patents grant inventors a temporary right to exclude competitors and earn supernormal profit during the patent term, letting them recoup R&D outlays and so providing a dynamic incentive to invest. Singapore’s strengthened IP enforcement, for instance, gives firms the confidence to locate R&D there. A government must consider whether its IP regime is credible enough to make private R&D worthwhile in the first place.
Opportunity cost, unintended consequences and government failure. Against these benefits stand the costs the government must weigh. Allocating resources to R&D carries an opportunity cost — the same funds could build infrastructure or healthcare. Granting patents confers monopoly power, letting firms charge high prices; for essential goods such as life-saving medicines this raises an equity problem, pricing the poor out. And government failure is possible if the cost of intervention exceeds its benefit — through mis-estimating the optimal subsidy, imperfect information, or administrative cost.
Evaluation and judgement. The decisive consideration is the cost–benefit comparison conducted under imperfect information, not any one rationale taken alone. The externality and non-excludability arguments establish why intervention can raise welfare, but they do not by themselves justify it: a government should intervene only where the expected social benefit exceeds the expected cost, and the magnitude of that net benefit varies sharply by market. Where the gain is large and reasonably certain — R&D into drugs for diseases like HIV, where technological innovation makes the payoff high — the case for subsidising or providing R&D is strong. Where the cost is high and the benefit unpredictable — speculative work such as harnessing nuclear fusion safely — governments tend, rightly, not to intervene. The reasoned stand is therefore that the government should intervene to internalise the external benefit to the extent that the expected benefit of doing so, net of opportunity cost and the risk of government failure, is positive — so the size of the marginal external benefit and the reliability of the information on it are the factors that ultimately govern the decision.